Microbot Medical Inc. (MBOT) Earnings Call Transcripts

Microbot Medical Inc.'s Latest Earnings Call - May 18, 2026

In the first quarter of fiscal year 2026, Microbot Medical Inc. reported significant commercial momentum following the full market release of its Liberty system. Revenue for the quarter exceeded total revenue from the previous quarter, driven by a doubling of accounts. Management indicated that the company is experiencing strong adoption rates and recurrent orders, suggesting robust demand for its innovative robotic system, which is expected to catalyze future growth. No specific revenue figures or earnings were disclosed during the call, but management expressed confidence in continued progress as they expand their market presence.

Reported metrics

Guidance from management

Management expressed confidence in continued growth and market penetration, indicating that they are aggressively pursuing additional opportunities. No specific revenue guidance was provided for future quarters.

What management said

And I think the fact that it's portable and disposable is extremely useful. One of the things that's very interesting, and so we did the first prostate [indiscernible] with the robot. We did the first transradial procedure is we actually had...

Yes. What did you hear the final portion we had 4 different attendings using it and all had great experience with it as well. So we have been pretty excited about its use here. And I'm happy to answer any questions people have.

What analysts pressed on

Analysts raised questions regarding the scalability of the Liberty system and its integration into existing hospital workflows. There were concerns about potential barriers to adoption among other medical professionals and the long-term sustainability of growth rates observed in the early adoption phase.

Main topics on the call

• Commercial Adoption of Liberty System — Management noted that 'revenue midway through the second quarter has already exceeded total first quarter revenue,' highlighting strong adoption and a doubling of accounts since the full market release. This reflects a s...
• Clinical Validation and Procedure Variety — The Liberty system has been utilized for various procedures including prostate artery embolization and genicular RT embolization, which have been endorsed by medical societies. This broadens the potential market and usag...
• User Experience and Satisfaction — Feedback from physicians indicated high satisfaction with the Liberty system, with Dr. Burke stating, 'patients are actually calling Emory and saying I want the procedure done robotically,' showcasing a shift in patient ...
• Market Expansion and Territory Coverage — Management reported that the Liberty system has been adopted in six states, with plans for further expansion. The successful onboarding of accounts in key sales territories indicates a strategic approach to market penetr...

Read the full Microbot Medical Inc. transcript (May 18, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 4 Microbot Medical Inc. earnings call transcripts on record, spanning August 26, 2020 to May 18, 2026. The most recent call on file is dated May 18, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

MBOT

Exchange

NasdaqCM

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

4

First call

August 26, 2020

Most recent

May 18, 2026